Richard Becker – Biography, Age, Medical Education, Career & Net Worth

Richard Becker (born January 1954) is a board-certified American cardiologist in Cincinnati, Ohio. He subspecializes in interventional cardiology and vascular medicine.

Becker is the Director and Physician-in-Chief, University of Cincinnati College of Medicine Heart, Lung and Vascular Institute.

Richard Becker Facts

• Full Name: Richard Clinton Becker
• Age: 68 years old
• Date of Birth: January 1954
• Occupation: Cardiologist
• Nationality: American

Richard Becker Medical School & Residency

• Cleveland Clinic Foundation, Fellowship Hospital — 1986
• Cleveland Clinic Foundation, Residency Hospital — 1986
• Cleveland Clinic Foundation, Internship Hospital — 1983
• University of Cincinnati / Main Campus, Medical School — 1982

Richard Becker Career

Becker represents the American Heart Association on a national level. He currently concentrates his research on molecular platforms for drug discovery, such as RNA aptamers and drug-antidote combinations, enhanced proteomics, and gene expression profiles.

Certifications & Licensure

• American Board of Internal Medicine – Certified in Internal Medicine
• OH State Medical License – Active through 2023
• MA State Medical License – Active through 2005
• NC State Medical License – Active through 2014

Hospital Affiliations

• University of Cincinnati Medical Center, Cincinnati, OH
• West Chester Hospital, West Chester, OH

• Cardiogenic Shock
• Coronary Artery Bypass (Heart Bypass)
• Deep Vein Thrombosis
• Acute Coronary Syndrome (ACS)
• Coronary Artery Angioplasty & Stent
• Atherosclerosis
• Inflammation
• Myocardial Infarction
• Blood Clot (Thromboembolism)
• Coronary Disease
• Vascular Disease
• Heart Disease (Myocardial Ischemia)
• Coronary Thrombosis
• Coronary Artery Disease (CAD)
• Arteriosclerosis (Arterial Disease)
• Stroke

Insurance Accepted

• Aetna Choice POS II
• Aetna Health Network Option Open Access
• Aetna HMO
• Aetna Managed Choice POS Open Access
• Aetna Signature Administrators PPO
• Aexcel PPO
• Ambetter Superior Health Plan
• Anthem Blue Access PPO
• Anthem Blue Preferred HMO
• Anthem Blue Preferred Plus POS
• BCBS Blue Card PPO
• BCBS IL PPO
• Buckeye Ambetter Balanced
• CareSource Just4Me OH
• CareSource Ohio
• CIGNA HMO
• CIGNA Open Access Plus
• CIGNA PPO
• First Health PPO
• Humana Choice POS
• Humana ChoiceCare Network PPO
• MEDICA CHOICE WITH UNITEDHEALTHC
• Medmutual OhioHealth Network MRF
• MMOH SuperMed HMO
• MMOH SuperMed POS Select
• MMOH SuperMed PPO Plus
• Molina Mrktplace OH MRF
• Molina place OH
• Multiplan PPO
• Sagamore Plus
• UHC Choice Plus POS
• UHC Navigate HMO
• UHC NAVIGATE PLUS POS
• UHC Navigate POS
• UHC Options PPO

Location & Contact Information

Expert Publications

Data provided by the National Library of Medicine

• Intramural hematoma of the thoracic aorta in a woman with neurofibromatosis.
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
• Choice of agents to limit the coagulation cascade in acute coronary syndromes.
• Antithrombotic therapy after myocardial infarction.
• Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.
• Circadian variations in acute myocardial infarction: patients or health care
• Factor Xa-A pleuripotential protease.
• The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.
• Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.
• Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
• When guidelines collide…
• Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapy.
• Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.
• Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.
• Thrombin: science and application in clinical practice

Richard Becker Net Worth

Richard Becker has an estimated net worth of $8 million.